Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CSMD1 (CUB and Sushi multiple domains 1) is an unusually large transmembrane protein containing alternating CUB and Sushi (also known as CCP, complement control protein) domains; specifically, it comprises 14 N-terminal CUB domains interspersed with Sushi domains, followed by an additional 15 Sushi domains at the C-terminus[1][2]. CSMD1 is expressed at high levels in the brain and is involved in inhibiting the classical and lectin pathways of complement activation by promoting factor I–mediated degradation of C4b and C3b and blocking the membrane attack complex (MAC) formation[2][4]. CSMD1 has a tumor-suppressor function in several cancers, with loss or reduction promoting cell migration, invasion, and carcinogenesis[1][5]. In the CNS, CSMD1 regulates synaptic pruning and neurodevelopment, and genetic variants are associated with increased risk for schizophrenia, intellectual disability, autism, and other neuropsychiatric diseases[3][4]. CSMD1’s levels in serum and mRNA have shown promise as biomarkers for psychosis and cancer prognosis[3]. Overall, CSMD1 is a multifunctional transmembrane complement regulator with emerging roles in immunology, neurodevelopment, and oncology.
Mechanisms involve inhibition of complement protein deposition and assembly, notably Factor I–mediated degradation of C3b and C4b, and inhibition of membrane attack complex (MAC) formation at C7
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CUB and Sushi multiple domains 1 (CSMD1).